🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,67 USD

Máx. histórico

61,25

1782 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,93%

Rango 52 semanas

23,62 – 31,04

Variación hoy

+0,49%

Cierre anterior

30,52

Rango de hoy

30,20 – 31,04

Volumen hoy

49.839.061

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,32%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
40,36 (puede no estar actualizado)
Dividend yield
5,64% (puede no estar actualizado)
Precio objetivo analistas
29,26 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,61%
Fecha de pago Importe por participación
03/11/2022 0,4000 USD
28/07/2022 0,4000 USD
12/05/2022 0,4000 USD
27/01/2022 0,4000 USD
04/11/2021 0,3900 USD
29/07/2021 0,3900 USD
06/05/2021 0,3900 USD
28/01/2021 0,3900 USD
05/11/2020 0,3605 USD
30/07/2020 0,3605 USD
07/05/2020 0,3605 USD
30/01/2020 0,3605 USD
07/11/2019 0,3416 USD
01/08/2019 0,3416 USD
09/05/2019 0,3416 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/06/2026 24,19 24,34 23,62 23,67 -1,54% 2,98% 57.859.500
24/06/2026 24,80 25,11 23,93 24,04 -2,75% 4,76% 76.962.600
23/06/2026 24,99 25,24 24,69 24,72 -1,44% 2,20% 82.009.200
22/06/2026 25,22 25,31 24,96 25,08 -0,52% 1,39% 41.119.100
18/06/2026 25,58 25,66 24,94 25,21 -2,74% 2,81% 119.614.300
17/06/2026 26,03 26,28 25,87 25,92 -0,46% 1,58% 31.117.500
16/06/2026 26,05 26,13 25,70 26,04 +0,15% 1,65% 32.829.600
15/06/2026 26,25 26,42 25,98 26,00 -0,80% 1,68% 34.194.100
12/06/2026 26,29 26,49 26,11 26,21 +0,15% 1,45% 38.773.000
11/06/2026 25,79 26,48 25,79 26,17 +2,23% 2,68% 45.268.700
10/06/2026 25,80 25,85 25,58 25,60 -0,39% 1,05% 30.376.300
09/06/2026 25,73 25,88 25,47 25,70 +0,31% 1,59% 35.273.200
08/06/2026 25,97 26,22 25,60 25,62 -1,61% 2,39% 42.028.800
05/06/2026 25,85 26,21 25,79 26,04 +1,36% 1,62% 32.218.500
04/06/2026 25,67 26,01 25,61 25,69 +1,38% 1,56% 31.272.000
03/06/2026 25,43 25,62 25,29 25,34 -0,82% 1,30% 30.957.100
02/06/2026 25,60 25,70 25,27 25,55 -0,31% 1,68% 31.295.700
01/06/2026 25,90 25,91 25,48 25,63 -2,10% 1,66% 35.553.600
29/05/2026 26,19 26,24 25,93 26,18 +0,15% 1,18% 48.284.200
28/05/2026 26,17 26,28 26,01 26,14 -0,27% 1,03% 25.651.800
27/05/2026 25,85 26,54 25,85 26,21 +1,39% 2,67% 39.024.700
26/05/2026 25,87 25,90 25,66 25,85 -0,19% 0,93% 29.084.700
22/05/2026 26,00 26,15 25,76 25,90 -0,19% 1,50% 22.320.000
21/05/2026 25,77 25,96 25,57 25,95 +0,62% 1,51% 20.181.500
20/05/2026 25,76 26,03 25,67 25,79 +0,51% 1,40% 35.574.200
19/05/2026 25,30 25,96 25,24 25,66 +1,30% 2,85% 41.036.700
18/05/2026 25,32 25,39 25,19 25,33 +0,00% 0,79% 34.111.300
15/05/2026 25,75 25,83 25,24 25,33 -1,63% 2,29% 37.110.100
14/05/2026 26,07 26,10 25,72 25,75 -0,81% 1,46% 24.102.700
13/05/2026 25,80 26,09 25,64 25,96 +0,35% 1,74% 39.420.000